These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 37908499)

  • 1. Gene therapy during
    Vervoorn MT; Amelink JJGJ; Ballan EM; Doevendans PA; Sluijter JPG; Mishra M; Boink GJJ; Bowles DE; van der Kaaij NP
    Front Cardiovasc Med; 2023; 10():1264449. PubMed ID: 37908499
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of ex-situ perfusion for thoracic organs.
    Roesel MJ; Wiegmann B; Ius F; Knosalla C; Iske J
    Curr Opin Organ Transplant; 2022 Oct; 27(5):466-473. PubMed ID: 35950888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transplanting Marginal Organs in the Era of Modern Machine Perfusion and Advanced Organ Monitoring.
    Resch T; Cardini B; Oberhuber R; Weissenbacher A; Dumfarth J; Krapf C; Boesmueller C; Oefner D; Grimm M; Schneeberger S
    Front Immunol; 2020; 11():631. PubMed ID: 32477321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Machine perfusion in organ transplantation: a tool for ex-vivo graft conditioning with mesenchymal stem cells?
    Van Raemdonck D; Neyrinck A; Rega F; Devos T; Pirenne J
    Curr Opin Organ Transplant; 2013 Feb; 18(1):24-33. PubMed ID: 23254699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A normothermic ex vivo organ perfusion delivery method for cardiac transplantation gene therapy.
    Bishawi M; Roan JN; Milano CA; Daneshmand MA; Schroder JN; Chiang Y; Lee FH; Brown ZD; Nevo A; Watson MJ; Rowell T; Paul S; Lezberg P; Walczak R; Bowles DE
    Sci Rep; 2019 May; 9(1):8029. PubMed ID: 31142753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA interference therapeutics in organ transplantation: The dawn of a new era.
    Brüggenwirth IMA; Martins PN
    Am J Transplant; 2020 Apr; 20(4):931-941. PubMed ID: 31680428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ex Vivo Mesenchymal Stem Cell Therapy to Regenerate Machine Perfused Organs.
    Bogensperger C; Hofmann J; Messner F; Resch T; Meszaros A; Cardini B; Weissenbacher A; Oberhuber R; Troppmair J; Öfner D; Schneeberger S; Hautz T
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34063399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pushing the boundaries of innovation: the potential of
    Iske J; Schroeter A; Knoedler S; Nazari-Shafti TZ; Wert L; Roesel MJ; Hennig F; Niehaus A; Kuehn C; Ius F; Falk V; Schmelzle M; Ruhparwar A; Haverich A; Knosalla C; Tullius SG; Vondran FWR; Wiegmann B
    Front Cardiovasc Med; 2023; 10():1272945. PubMed ID: 37900569
    [No Abstract]   [Full Text] [Related]  

  • 9. Ex-situ oxygenated hypothermic machine perfusion in donation after circulatory death heart transplantation following either direct procurement or in-situ normothermic regional perfusion.
    Moeslund N; Ertugrul IA; Hu MA; Dalsgaard FF; Ilkjaer LB; Ryhammer P; Pedersen M; Erasmus ME; Eiskjaer H
    J Heart Lung Transplant; 2023 Jun; 42(6):730-740. PubMed ID: 36918339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ex Vivo Delivery of Viral Vectors by Organ Perfusion for Cardiac Transplantation Gene Therapy.
    Pla MM; Evans A; Lezberg P; Bowles DE
    Methods Mol Biol; 2022; 2573():249-259. PubMed ID: 36040600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The current status of stem cell-based therapies during ex vivo graft perfusion: An integrated review of four organs.
    Luijmes SH; Verstegen MMA; Hoogduijn MJ; Seghers L; Minnee RC; Mahtab EAF; Taverne YJHJ; Reinders MEJ; van der Laan LJW; de Jonge J
    Am J Transplant; 2022 Dec; 22(12):2723-2739. PubMed ID: 35896477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ischemia/reperfusion during normothermic perfusion.
    Tillou X; Thuret R; Doerfler A;
    Prog Urol; 2014 Jun; 24 Suppl 1():S51-5. PubMed ID: 24950934
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Pinnelas R; Kobashigawa JA
    Future Cardiol; 2022 Jan; 18(1):5-15. PubMed ID: 34503344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal Delivery of Pharmacologic Agents During Machine Perfusion to Prevent Ischaemia-Reperfusion Injury: From Murine Model to Clinical Trials.
    Franzin R; Stasi A; Fiorentino M; Simone S; Oberbauer R; Castellano G; Gesualdo L
    Front Immunol; 2021; 12():673562. PubMed ID: 34295329
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Zulpaite R; Miknevicius P; Leber B; Strupas K; Stiegler P; Schemmer P
    Front Med (Lausanne); 2021; 8():808719. PubMed ID: 35004787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ex situ heart perfusion: The past, the present, and the future.
    Wang L; MacGowan GA; Ali S; Dark JH
    J Heart Lung Transplant; 2021 Jan; 40(1):69-86. PubMed ID: 33162304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene Silencing With siRNA (RNA Interference): A New Therapeutic Option During Ex Vivo Machine Liver Perfusion Preservation.
    Thijssen MF; Brüggenwirth IMA; Gillooly A; Khvorova A; Kowalik TF; Martins PN
    Liver Transpl; 2019 Jan; 25(1):140-151. PubMed ID: 30561891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Machine perfusion of circulatory determined death hearts: A scoping review.
    Saemann L; Guo Y; Ding Q; Zhou P; Karck M; Szabó G; Wenzel F
    Transplant Rev (Orlando); 2020 Jul; 34(3):100551. PubMed ID: 32498975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of Mesenchymal Stem Cells During Machine Perfusion: An Emerging Novel Strategy for Organ Preservation.
    Li J; Peng Q; Yang R; Li K; Zhu P; Zhu Y; Zhou P; Szabó G; Zheng S
    Front Immunol; 2021; 12():713920. PubMed ID: 35024039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ex vivo approach to treat failing organs: expanding the limits.
    Ciubotaru A; Haverich A
    Eur Surg Res; 2015; 54(1-2):64-74. PubMed ID: 25358862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.